1. View quote in context »
    The institute last year negotiated certain intellectual property and manufacturing rights to AIDSVAX from VaxGen. "As the first HIV vaccine trial to demonstrate some level of reduced infection among the entire trial population, this is an encouraging step forward in the struggle to develop an effective HIV/AIDS vaccine" Francis said in a press release. Full Article at San Francisco Business Times
    As the first HIV vaccine trial to demonstrate some level of reduced infection among the entire trial population, this is an encouraging step forward in the struggle to develop an effective HIV/AIDS vaccine
    San Francisco San Francisco SOURCE: San Francisco Business Times 2 months ago